drugset / Trial / NCT00668642
Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer
Phase 2
Completed
20 enrolled
Endeavor Health
Northwestern University · collabUniversity of Chicago · collab
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to determine if the drug dutasteride increases expression of genes that slow the growth of prostate cancer during treatment with intermittent androgen ablation therapy (hormone therapy).
Timeline
- Start
- 2007-03
- Primary completion
- 2013-05
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dutasteride | Small molecule | 0.5 mg | Oral |